title: Editorial: are regulatory B10 cells a viable target for autoimmune diseases?
authors.affiliation: 1.205 South Orange Ave., NJMS-UH Cancer Center, Newark, NJ 07960, USA. barnesbe@umdnj.edu.
authors.forename: Betsy J
authors.initials: BJ
authors.lastname: Barnes
mesh_terms: D000634:Aminoquinolines / Q000009:adverse effects*; D000818:Animals; D060151:B-Lymphocytes, Regulatory / Q000276:immunology*; D006801:Humans; D000077271:Imiquimod; D007249:Inflammation / Q000139:chemically induced* / Q000276:immunology*; D011565:Psoriasis / Q000139:chemically induced* / Q000276:immunology*; D012867:Skin / Q000473:pathology*
chemical_list: D000634:Aminoquinolines; D000077271:Imiquimod
keywords: B cell; autoimmunity; interleukin 10